Dick's Sporting, Intuitive Surgical, Toast On CNBC’s ‘Final Trades’ - Dick's Sporting Goods (NYSE:DKS), Intuitive Surgical (NASDAQ:ISRG)
Benzinga· 2025-12-19 12:59
On CNBC's “Halftime Report Final Trades,” Hightower Advisors’ Stephanie Link said Dick’s Sporting Goods, Inc. (NYSE:DKS) is down 11% from its highs and trades at 11 times earnings. They will fix Foot Locker, Link added. Dick’s completed its purchase of Foot Locker in September.On the earnings front, Dick's Sporting, on Nov. 26, delivered stronger-than-expected results in its core business and lifted full-year guidance. The company reported third-quarter sales of $4.168 billion (+36.3% year over year), which ...
An Imminent War In Venezuela: Oil Could Spike Above $80
Seeking Alpha· 2025-12-19 12:59
We are in the process of accelerating deglobalization. The process of de-globalization involves decoupling into two blocks: 1) the US-led block with the EU allies and other NATO members, and 2) the China-led block, together with Russia, Iran, and North Korea.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am n ...
American Outdoor Brands, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AOUT) 2025-12-19
Seeking Alpha· 2025-12-19 12:58
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
BioMarin to acquire Amicus Therapeutics for $4.8 Billion
Reuters· 2025-12-19 12:56
Core Viewpoint - BioMarin Pharmaceutical is set to acquire Amicus Therapeutics in an all-cash transaction valued at approximately $4.8 billion [1] Company Summary - The acquisition will enhance BioMarin's portfolio and expand its capabilities in the biotechnology sector [1] - The deal signifies BioMarin's strategic move to strengthen its position in the market through consolidation [1] Financial Summary - The total value of the acquisition is around $4.8 billion, indicating a significant investment by BioMarin [1]
Gold market analysis for December 19 - key intra-day price entry levels for active traders
KITCO· 2025-12-19 12:55
Core Insights - Jim Wyckoff has over 25 years of experience in stock, financial, and commodity markets, including roles as a financial journalist and market analyst [1][2] - He has covered all futures markets traded in the U.S. and has worked with various news and advisory services [1][2] Company and Industry Summary - Jim Wyckoff operates the "Jim Wyckoff on the Markets" analytical, educational, and trading advisory service [2] - He has held positions as a technical analyst for Dow Jones Newswires and as a senior market analyst with TraderPlanet.com [2] - Wyckoff is also a consultant for the "Pro Farmer" agricultural advisory service and was the head equities analyst at CapitalistEdge.com [2] - He provides daily market updates and technical analysis on Kitco.com [3]
Orsted - The ADR Disconnect "HOLD"/Rotate Rating Was Correct (Rating Upgrade) (OTCMKTS:DNNGY)
Seeking Alpha· 2025-12-19 12:55
Core Viewpoint - Ørsted A/S (DNNGY) has been assigned a "HOLD" rating due to valuation discrepancies related to volume and other trends [1] Group 1: Company Analysis - The company is under the coverage of a senior analyst with over 10 years of experience in generating value ideas in European and North American markets [1] - The analyst focuses on markets in Scandinavia, Germany, France, the UK, Italy, Spain, Portugal, and Eastern Europe to identify reasonably valued stock ideas [1]
Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing
Youtube· 2025-12-19 12:53
President Trump has signed an executive order to reclassify marijuana from a schedule one to a schedule three drug. While not making it fully legal, it would ease federal restrictions. Joining us right now with what this means for the marijuana industry and personal consumption is Kevin Sabbat.He is the CEO of Smart Approaches to Marijuana, a former White House Drug Policy Advisor, and he's the author of One Nation Under the Influence. Kevin, first of all, thank you uh for being here. It's been a while sinc ...
Markets quietly welcome EU shift to joint borrowing for Ukraine loan
Reuters· 2025-12-19 12:52
Investors welcomed the European Union's decision to fund lending to Ukraine through borrowing on Friday, saying it cemented the use of joint debt as a financing solution while avoiding a legally contentious plan to use Russia's frozen assets. ...
Union Pacific, Norfolk submit papers for regulatory review of $85 billion merger
Reuters· 2025-12-19 12:52
Core Viewpoint - Union Pacific and Norfolk Southern have applied to the U.S. transport regulator to review their proposed $85 billion merger, which aims to establish the first coast-to-coast freight railroad in the United States [1] Company Summary - The merger between Union Pacific and Norfolk Southern is valued at $85 billion, indicating a significant consolidation in the freight railroad industry [1] - If approved, this merger would create the first coast-to-coast freight railroad in the nation, potentially transforming logistics and transportation dynamics [1]
BP’s C-suite milestone: Women in both the CEO and CFO seats
Fortune· 2025-12-19 12:51
Good morning. BP makes history in its C-suite.Fortune’s energy editor, Jordan Blum, reported that BP hired Woodside Energy leader Meg O’Neill as CEO, effective April 1. Current BP CEO Murray Auchincloss stepped down on Thursday but will serve in an advisory role through 2026, while Carol Howle, BP’s EVP of supply, trading, and shipping, will serve as interim CEO.O’Neill will become the first-ever woman chief executive of a Big Oil giant—typically defined as BP, Shell, Exxon Mobil, Chevron, and TotalEnergies ...